Cannapharmarx, Inc. financial data

Symbol
CPMD on OTC
Location
Suite 3600, 888 3 Rd Street Sw, Calgary, Alberta, Canada
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - May 16, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.66 % +408%
Debt-to-equity -144 % +49.5%
Return On Equity -6.09 % -118%
Return On Assets -78.8 % +45.3%
Operating Margin -6.39K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 663M shares 0%
Common Stock, Shares, Outstanding 663M shares +18.4%
Entity Public Float 9.28M USD
Common Stock, Value, Issued 66.3K USD +10.5%
Weighted Average Number of Shares Outstanding, Basic 663M shares +89%
Weighted Average Number of Shares Outstanding, Diluted 663M shares +125%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 335K USD +1198%
General and Administrative Expense 27.7K USD -86.7%
Operating Income (Loss) -668K USD +15.5%
Nonoperating Income (Expense) -22.9K USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -8.24M USD +31%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent 1.12M USD +94.1%
Earnings Per Share, Basic -0.03 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.21K USD -44%
Accounts Receivable, after Allowance for Credit Loss, Current 14.1K USD
Inventory, Net 951K USD +0.09%
Other Assets, Current 0 USD -100%
Assets, Current 1.24M USD +18.1%
Property, Plant and Equipment, Net 130K USD -13.4%
Operating Lease, Right-of-Use Asset 5.35M USD -5.32%
Assets 11.2M USD -1.16%
Accounts Payable, Current 5.07M USD -38.8%
Accrued Liabilities, Current 4.25M USD
Liabilities, Current 26.9M USD -8.07%
Liabilities 31.7M USD -9.04%
Accumulated Other Comprehensive Income (Loss), Net of Tax 549K USD +540%
Retained Earnings (Accumulated Deficit) -102M USD -0.68%
Stockholders' Equity Attributable to Parent -20.5M USD +12.8%
Liabilities and Equity 11.2M USD -1.16%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -601K USD -9.58%
Net Cash Provided by (Used in) Financing Activities 600K USD +7.17%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 5B shares 0%
Common Stock, Shares, Issued 663M shares +18.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -948 USD -108%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.21K USD -90%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Depreciation 0 USD -100%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -697K USD +94%
Property, Plant and Equipment, Gross 211K USD +3.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.17 pure
Deferred Tax Assets, Operating Loss Carryforwards 24.6M USD +3.07%
Preferred Stock, Shares Authorized 3.2M shares
Operating Lease, Payments 261K USD +29.1%
Additional Paid in Capital 80.1M USD +1.82%
Depreciation, Depletion and Amortization 0 USD -100%
Deferred Tax Assets, Net of Valuation Allowance 25M USD +3.2%
Interest Expense 616K USD +6.78%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%